Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.9350
+0.0468 (5.27%)
At close: Sep 5, 2025, 4:00 PM
0.9299
-0.0051 (-0.55%)
After-hours: Sep 5, 2025, 7:47 PM EDT

Outlook Therapeutics Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2016 - 2020
1.51-----
Upgrade
Cost of Revenue
41.8841.7626.4542.3338.9626.34
Upgrade
Gross Profit
-40.37-41.76-26.45-42.33-38.96-26.34
Upgrade
Selling, General & Admin
39.9729.9426.6720.7412.779.97
Upgrade
Operating Expenses
32.2529.9426.6720.7412.779.97
Upgrade
Operating Income
-72.62-71.7-53.13-63.07-51.73-36.31
Upgrade
Interest Expense
-0.69-3.16-2.53-1.49-0.94-1.76
Upgrade
Interest & Investment Income
0.910.910.97---
Upgrade
Earnings From Equity Investments
-0.12-0.1-0.01-0.05-0.05-
Upgrade
Other Non Operating Income (Expenses)
35.331.150.050.47-0.451.98
Upgrade
EBT Excluding Unusual Items
-37.19-72.91-54.65-64.14-53.16-36.09
Upgrade
Asset Writedown
------0.53
Upgrade
Other Unusual Items
-6.25-2.46-4.33-1.91--1.9
Upgrade
Pretax Income
-43.44-75.36-58.98-66.05-53.16-38.51
Upgrade
Income Tax Expense
00000-3.27
Upgrade
Earnings From Continuing Operations
-43.44-75.37-58.98-66.05-53.16-35.24
Upgrade
Net Income
-43.44-75.37-58.98-66.05-53.16-35.24
Upgrade
Preferred Dividends & Other Adjustments
-----13.63
Upgrade
Net Income to Common
-43.44-75.37-58.98-66.05-53.16-48.87
Upgrade
Shares Outstanding (Basic)
2919131184
Upgrade
Shares Outstanding (Diluted)
2919131184
Upgrade
Shares Change (YoY)
82.32%48.29%17.96%38.91%110.43%298.84%
Upgrade
EPS (Basic)
-1.50-4.06-4.72-6.23-6.96-13.47
Upgrade
EPS (Diluted)
-1.50-4.06-4.72-6.23-6.96-13.47
Upgrade
Free Cash Flow
-56.43-68.79-42.97-56.67-54.25-31.79
Upgrade
Free Cash Flow Per Share
-1.95-3.71-3.44-5.34-7.11-8.76
Upgrade
Operating Margin
-4824.52%-----
Upgrade
Profit Margin
-2885.82%-----
Upgrade
Free Cash Flow Margin
-3748.97%-----
Upgrade
EBITDA
-72.51-71.59-53.08-62.87-51.46-35.76
Upgrade
D&A For EBITDA
0.120.110.040.20.260.55
Upgrade
EBIT
-72.62-71.7-53.13-63.07-51.73-36.31
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q